NCT06315023
The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)
Enrolling by Invitation
Not specifiedAll AgesObservationalEndologix
~450 participants
Updated 2026-05-12 on ClinicalTrials.gov
What's tested:DETOUR System
At a glance
Recruiting sites
0 of 10 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Freedom from CD-TLR
Measured over 1 Year
+1 more outcome measured
Conditions
Where it's being run
10 sites across 9 statesPennsylvania2
California1
Connecticut1
District of Columbia1
Florida1
Massachusetts1
Missouri1
New York1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Freedom from CD-TLR1 Year
Primary Effectiveness outcome is patency as defined as Freedom from Clinical Driven Target Lesion Revascularization (CD-TLR)
- Freedom from MAE30 Days
Primary Safety outcome is freedom from a major adverse event (MAE) at 30 days post-procedure defined as any occurrence of the following events: Death, Clinically-Driven Target Lesion Revascularization (CD-TLR), and/or Major Amputation of the Treated Limb.